Citation: Jwm. Cheng et Sn. Balwin, L-arginine in the management of cardiovascular diseases (vol 35, pg 755, 2001), ANN PHARMAC, 35(7-8), 2001, pp. 965-965
Authors:
Spinler, SA
Hilleman, DE
Cheng, JWM
Howard, PA
Mauro, VF
Lopez, LM
Munger, MA
Gardner, SF
Nappi, JM
Citation: Sa. Spinler et al., New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines, ANN PHARMAC, 35(5), 2001, pp. 589-617
Citation: Jwm. Cheng et al., Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, PHARMACOTHE, 21(7), 2001, pp. 828-841
Citation: Cg. Sotiriou et Jwm. Cheng, Beneficial effects of statins in coronary artery disease - Beyond loweringcholesterol, ANN PHARMAC, 34(12), 2000, pp. 1432-1439
Authors:
Spinler, SA
Al-Jazairi, AS
Cheng, JWM
Kapoor, S
Kobrin, S
Shaw, L
Citation: Sa. Spinler et al., Predictive performance study of two digoxin assays in subjects with various degrees of renal function, THER DRUG M, 22(6), 2000, pp. 729-736
Citation: O. Bessmertny et Jwm. Cheng, Overview of platelet glycoprotein IIb IIIa receptor antagonist treatment in the management of coronary interventions and acute ischemic coronary syndromes, AM J M CARE, 5(5), 1999, pp. 643-655
Citation: Jwm. Cheng et al., Probabilistic security analysis of bilateral transactions in a deregulatedenvironment, IEEE POW SY, 14(3), 1999, pp. 1153-1159